One of the main challenges in targeting SHP2 is achieving specificity. SHP2 shares structural similarities with other [protein tyrosine phosphatases](), making it difficult to develop inhibitors that are both effective and selective. Additionally, the complex role of SHP2 in various signaling pathways means that inhibiting it could have broad and potentially harmful effects on normal cellular functions.
